Abstract:Objective To investigate the association of serum ghrelin level with cognition in T2DM patients. Methods In this study 195 T2DM patients cared at Tangshan Gongren Hospital from June 2015 to August 2016 were recruited. Data including age, gender, education, duration of illness and BMI were recorded, and clinical parameters including FPG, HbA1c, TC, TG, LDL and HDL were collected. Ghrelin was measured by ELISA. Cognitive performance was assessed by the Mini-mental State Examination (MMSE) and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). All patients were divided into two groups including cognitive impairment group and non-cognitive impairment group by MMSE. The general data and cognitive function were compared between the two groups. Results Serum ghrelin level in the cognitive impairment group was significantly lower than that of the non-cognitive impairment group. Logistic regression analysis showed that ghrelin was the protective factor of cognition in the T2DM patients (P < 0.05). Serum ghrelin level was positively correlated with RBANS scores excluding visuospatial/constructional score in the T2DM patients, which included immediate memory, language,attention, delayed memory and total scores (P < 0.05). Conclusions T2DM patients with cognitive impairment have low level of serum ghrelin, and serum ghrelin is postively correlated with their cognitive performance, suggesting that serum ghrelin may be involved in cognitive deficit of T2DM patients.